Lars Pedersen
Overview
Explore the profile of Lars Pedersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
422
Citations
11692
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang S, Pedersen L, Skakkebaek A, Berglund A, Gravholt C
Lancet Reg Health Eur
. 2025 Feb;
51:101230.
PMID: 39973943
Background: Men with Klinefelter syndrome (KS) have hypogonadism, increased morbidity, and excess mortality. Testosterone replacement therapy (TRT) has the potential to alleviate this burden. We assessed the risk of major...
2.
Olesen A, Miger K, Sajadieh A, Abild-Nielsen A, Pedersen L, Schultz H, et al.
Int J Cardiol
. 2025 Feb;
425:133068.
PMID: 39956459
Background: Remote Dielectric Sensing (ReDS) is a fast and non-invasive method that estimates lung fluid. We previously described moderate accuracies for ReDS to detect acute heart failure in consecutive patients....
3.
Bonnesen K, Heide-Jorgensen U, Christensen D, Christiansen C, Lash T, Hennessy S, et al.
JAMA Intern Med
. 2025 Jan;
185(3):314-323.
PMID: 39836391
Importance: No large randomized clinical trial has directly compared empagliflozin with dapagliflozin, leaving their comparative effectiveness regarding kidney outcomes unknown. Objective: To compare kidney outcomes between initiation of empagliflozin vs...
4.
Rosenkrantz O, Wheler J, Westphal Thrane M, Pedersen L, Sorensen H
Clin Epidemiol
. 2024 Nov;
16:783-792.
PMID: 39559743
Background: The Danish National Hospital Medication Register (DHMR), one of the first nationwide in-hospital medication registries in the world, contains detailed information on medication administration and dispensing. Objective: To provide...
5.
Eika J, Bonnesen K, Pedersen L, Ehrenstein V, Sorensen H, Schmidt M
Clin Epidemiol
. 2024 Nov;
16:793-802.
PMID: 39559742
Purpose: Ibuprofen is used to treat acute pericarditis, but high-dose ibuprofen has also been associated with increased cardiovascular risks. We examined the cardiovascular safety of using ibuprofen for acute pericarditis....
6.
Petersen S, Bonnesen K, Grove E, Pedersen L, Schmidt M
Eur Heart J
. 2024 Nov;
46(1):58-68.
PMID: 39551938
Background And Aims: The bleeding risk of using non-steroidal anti-inflammatory drugs (NSAIDs) in patients treated with oral anticoagulants for venous thromboembolism (VTE) remains unclear. Methods: A nationwide cohort study of...
7.
Lanting V, Vago E, Horvath-Puho E, Mulder F, Di Nisio M, Kamphuisen P, et al.
J Thromb Haemost
. 2024 Oct;
23(2):600-609.
PMID: 39481543
Background: Guidelines recommend using risk assessment tools to identify ambulatory patients with cancer at high risk of venous thromboembolism (VTE). Objectives: We aimed to validate a new cancer-associated thrombosis (CAT)...
8.
Foverskov E, White J, Froslev T, Pedersen L, Sorensen H, Hamad R
Pediatrics
. 2024 Oct;
154(5).
PMID: 39429017
Objective: To examine the association between neighborhood socioeconomic disadvantage and birth outcomes among refugee women in Denmark, leveraging a natural experiment. Methods: This register-based study included 15 118 infants born...
9.
Costello R, Pedersen L, Henderson A, Tazare J, Sorensen H, Vandenbroucke J, et al.
BMJ Open
. 2024 Oct;
14(10):e088710.
PMID: 39414266
Objectives: To examine the impact of the COVID-19 pandemic on deprivation-related inequalities in hospitalisations for cardiovascular disease (CVD) conditions in Denmark and England between March 2018 and December 2021. Design:...
10.
Bonnesen K, Korsholm K, Andersen A, Pedersen L, Simonsen C, Nielsen-Kudsk J, et al.
J Am Coll Cardiol
. 2024 Oct;
84(15):1424-1433.
PMID: 39357939
Background: Transcatheter patent foramen ovale (PFO) closure is the recommended treatment for patients age 18 to 60 years with cryptogenic stroke having a high probability of being PFO-related. Limited data...